2-oxothiazolidine-4-carboxylic acid has been researched along with Asthma, Bronchial in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeon, MS; Kim, SR; Lee, HB; Lee, KS; Lee, SJ; Lee, YC; Park, SJ; Park, SY | 1 |
| Choi, IW; Im, MJ; Kim, UH; Lee, HK; Lee, KS; Lee, YC; Lim, JS; Park, HS; Park, KH; Park, SJ | 1 |
| Jin, SM; Kim, CY; Kim, SR; Kim, UH; Lee, KS; Lee, YC; Min, KH; Park, HS; Park, KH; Park, SJ | 1 |
| Lee, YC; Park, SJ | 1 |
| Jin, SM; Kim, SR; Lee, KS; Lee, YC; Li, L; Min, KH; Park, HS; Park, SJ | 1 |
1 review(s) available for 2-oxothiazolidine-4-carboxylic acid and Asthma, Bronchial
| Article | Year |
|---|---|
Antioxidants as novel agents for asthma.
Topics: Acetylcysteine; Anti-Asthmatic Agents; Antioxidants; Asthma; Cysteine; Glutathione; Humans; Oxidative Stress; Pyrrolidonecarboxylic Acid; Reactive Oxygen Species; Thiazoles; Thiazolidines | 2006 |
4 other study(ies) available for 2-oxothiazolidine-4-carboxylic acid and Asthma, Bronchial
| Article | Year |
|---|---|
L-2-Oxothiazolidine-4-carboxylic acid or α-lipoic acid attenuates airway remodeling: involvement of nuclear factor-κB (NF-κB), nuclear factor erythroid 2p45-related factor-2 (Nrf2), and hypoxia-inducible factor (HIF).
Topics: Airway Remodeling; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Basic Helix-Loop-Helix Transcription Factors; Drug Evaluation, Preclinical; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; MAP Kinase Signaling System; Mice, Inbred C57BL; Muscle, Smooth; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Pyrrolidonecarboxylic Acid; Thiazolidines; Thioctic Acid; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2012 |
Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchitis; Cell Adhesion Molecules; Chemokines; Disease Models, Animal; Eosinophil Cationic Protein; Interleukins; Lung; Mice; NF-kappa B; Ovalbumin; Prodrugs; Pyrrolidonecarboxylic Acid; Reactive Oxygen Species; Thiazoles; Thiazolidines | 2004 |
A prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, regulates vascular permeability by reducing vascular endothelial growth factor expression in asthma.
Topics: Animals; Asthma; Capillary Permeability; Female; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphatidylinositol 3-Kinases; Phosphorylation; Prodrugs; Pyrrolidonecarboxylic Acid; Reactive Oxygen Species; Thiazoles; Thiazolidines; Thioctic Acid; Vascular Endothelial Growth Factor A | 2005 |
An antioxidant modulates expression of receptor activator of NF-kappaB in asthma.
Topics: Animals; Antioxidants; Asthma; Blotting, Western; Bronchoalveolar Lavage Fluid; Capillary Permeability; Female; Gene Expression; Glycoproteins; Immunohistochemistry; Mice; Mice, Inbred C57BL; Osteoprotegerin; Ovalbumin; Phosphorylation; Prodrugs; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrrolidonecarboxylic Acid; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Receptors, Vascular Endothelial Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazoles; Thiazolidines; Vascular Endothelial Growth Factor A | 2006 |